Compare StocksEMR vs PFE

Emerson Electric Co. (EMR) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-09-17, EMR is overvalued at $148, with a DCF intrinsic value of $132 and a margin of safety of -12%. PFE is overvalued at $28, with an intrinsic value of $22 and a margin of safety of -23%. Of the two, EMR has the wider margin of safety.

EMR
Emerson Electric Co.
$147.93
VS
PFE
Pfizer Inc.
$27.64

Rewards

EMR
  • Altman Z-Score of 4.10 indicates very low bankruptcy risk — the company is firmly in the safe zone.
PFE
  • Gross margin of 74.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.

Risks

EMR
  • Trailing P/E of 32.4x is 44% above the historical average of 22.6x — the stock trades at a premium to its own history.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • FCF yield of 7.9% suggests reasonable valuation assuming continued moderate growth.
  • PEG ratio of 12.68 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
EMR
PFE
Valuation
$3.71B
Free Cash Flow
$12.49B
4.49%
FCF Yield
7.93%
32.44
Trailing P/E
36.36
20.42
Forward P/E
9.54
Quality & Moat
11.59%
ROIC
9.42%
12.80%
ROE
5.01%
53.16%
Gross Margin
74.72%
1.71
PEG Ratio
12.68
Balance Sheet Safety
0.57
Net Debt / Equity
0.61
N/A
Interest Coverage
N/A
1.92
Net Debt / EBITDA
2.04
1.52%
Dividend Yield
6.26%
EMR: 6Ties: 1PFE: 5
EMRPFE

Historical Fundamentals

Learn more →
EMR

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
EMR
$1.29
created per $1 retained over 3 years
Value Creator
Σ Retained
$13.89B
Δ Market Cap
+$17.88B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
EMR
12.2% Overvalued
Price is 12.2% above estimated fair value
Current Price: $147.93
Fair Value: $131.88
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
23.2% Overvalued
Price is 23.2% above estimated fair value
Current Price: $27.64
Fair Value: $22.43
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
EMR

What growth rate is the market pricing in at $148?

+12.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +11.0%

The market implies +12.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +11.0%, reflecting heavy growth investment.

PFE

What growth rate is the market pricing in at $28?

+6.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +5.3%

The market implies +6.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +5.3%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
EMR
61/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
EMR
-2.75
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
EMR
Insiders 0.3%Institutions 84.1%Retail & Other 15.7%
No. of Institutional Holders2,884
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.1%Retail & Other 30.8%
No. of Institutional Holders3,645
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
EMR
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
EMR
1
Sells (3M)
5
Sells (12M)
Total value (12M): $3.88M
TRAIN MICHAEL H
Officer
$1.17M
@ $158.99 · 2026-08-06
LEVATICH MATTHEW S
Director
$239,349
@ $162.16 · 2026-02-10
PIAZZA NICHOLAS J
Officer
$1.07M
@ $159.07 · 2026-02-09
BLINN MARK A
Director
$438,930
@ $152.62 · 2026-02-05
KARSANBHAI SURENDRALAL LANCA
Chief Executive Officer
$965,979
@ $133.00 · 2025-12-03
TRAIN MICHAEL H
Officer
$3.38M
@ $119.44 · 2025-05-12
LEVATICH MATTHEW S
Director
$233,472
@ $125.05 · 2025-02-12
BLINN MARK A
Director
$2,505
@ $125.25 · 2025-02-12
BLINN MARK A
Director
$234,701
@ $125.71 · 2025-02-10
TRAIN MICHAEL H
Officer
$2.71M
@ $125.96 · 2024-11-06
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
0
Sells (3M)
0
Sells (12M)
No open market insider sales found.
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
EMR
FearGreed
😐Neutral(53/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(60/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
EMR
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (53)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (60)
View EMR Full AnalysisView PFE Full Analysis

Frequently Asked Questions: EMR vs PFE

Is Emerson Electric Co. or Pfizer Inc. more undervalued in 2026?

Based on our discounted cash flow model, EMR trades at a -12.2% margin of safety (intrinsic value $132 vs. price $148), compared to PFE's -23.2% margin of safety (intrinsic $22 vs. $28).

Which stock has a wider economic moat, Emerson Electric Co. or Pfizer Inc.?

EMR scores 61/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Pfizer Inc. in financial distress?

PFE's Altman Z-Score of 2.1 places it in the Grey zone, signaling elevated bankruptcy risk. EMR scores 4.1 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Emerson Electric Co. or Pfizer Inc.?

Pfizer Inc. (PFE) generates a 7.9% free cash flow yield, compared to Emerson Electric Co.'s 4.5%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Emerson Electric Co. or Pfizer Inc.?

EMR earns 11.6% ROIC versus PFE's 9.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Emerson Electric Co.'s or Pfizer Inc.'s?

EMR's dividend earns a safety score of 84/100 (Very Safe), compared to PFE's 24/100 (Unsafe). EMR has raised its dividend for 3 consecutive years.